Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Clinical trial NCT01478399 · COMPLETED
Trial details
- NCT number
- NCT01478399
- Sponsor
- PhaseBio Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-10-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.